PECULIARITIES OF LEVEL OF THE GASTROINTESTINAL TRACT IN CORONAVIRUS DISEASE (COVID-19) IN DIFFERENT WAVES OF THE PANDEMIC

Authors

  • T. O. Pertseva Dnipro State Medical University
  • L. I. Konopkina Dnipro State Medical University
  • K. O. Belosludtseva Dnipro State Medical University
  • O. V. Myronenko Dnipro State Medical University
  • L. A. Botvinikova Dnipro State Medical University
  • O. O. Shchudro Dnipro State Medical University
  • Yu. V. Huba Dnipro State Medical University

DOI:

https://doi.org/10.11603/1811-2471.2021.v.i4.12514

Keywords:

coronavirus disease, COVID-19, gastrointestinal symptoms

Abstract

ABSTRACT. Today, patients with COVID-19 perform not only respiratory symptoms. One of the most common atypical symptoms are gastrointestinal.

The aim of the study was to evaluate the frequency of gastrointestinal symptoms in patients with coronavirus disease (COVID-19) in different waves of the pandemic in the Dnieper region.

Materials and methods. 68 patients with verified coronavirus disease (COVID-19) were examined. All of them formed the main group, which was divided into three subgroups depending on the period in which the disease developed: subgroup 1 included 19 patients (mean age – 53,1 ± 3,3 years; men - 10 (52,6%) , women - 9 (47,4%)) who were hospitalized in the period from October 2020 to January 2021; to subgroup 2 - 27 patients (average age – 57,3 ± 2,5 years, men - 12 (44,4%), women - 15 (55,6%)), who were hospitalized in the period from March to May 2021 year; to subgroup 3 - 22 patients (average age - 56.2 ± 4.7 years, men - 9 (40.9%), women - 13 (59.1%)), who were hospitalized in the period from September to November 2021 year. Examination of patients included evaluation of physical status  by clinical methods.

Results. Manifestation of gastroenterological symptoms in all patients was on average 5,3 ± 2,9 days from the onset of the disease and did not differ by subgroup (p > 0,05). Nausea was observed in almost every sixth patient and in most cases was accompanied by vomiting, with no significant difference between subgroups (p > 0,05). 6 (27,3%) patients of the 3rd subgroup complained of vomiting, which was significantly more often than in the 2nd subgroup (1 (3,7%) patients) (p = 0,020). All patients of the 1st and 2nd subgroups reported single vomiting, which brought relief and did not require medical intervention, while four patients of the 3rd subgroup (66,7%) had vomiting more than once (mean 2,5 ± 0,5 times). Abdominal pain was almost non-existent in the cohort of subjects and the frequency of symptoms did not differ significantly between subgroups (p > 0,05), it was quite strong, which disrupted the daily activities of patients. Diarrhea in subgroup 3 bothered patients significantly more often than in subgroup 2 (p = 0,013). Prolonged diarrhea was detected in patients of subgroup 3 (3,4 ± 0,7 days) than in patients of subgroup 1 (1,2 ± 0,3 days) (p < 0.0001), which required the appointment of rehydration therapy. Analysis of the combination of gastroenterological symptoms in patients with COVID-19 showed that the most common symptom was nausea or diarrhea, no difference between subgroups was found (p > 0,05).

Conclusions. Nausea, vomiting, abdominal pain and diarrhea are the most common gastrointestinal symptoms of COVID-19, and in the Dnieper region, vomiting and diarrhea were significantly more common in autumn 2021 than in spring 2021. In the presence of gastroenterological symptoms in a COVID-19 pandemic, patients must be excluded from SARS-CoV-2 infection.

References

Feshchenko, Yu.I., Holubovska, O.A., Dziublyk, O.Ya., Havrysiuk, V.K., Dziublyk, Ya.O., & Liskina, I.V. (2021). Osoblivosti urazhennia lehen pry COVID-19 [Pulmonary disease in COVID-19]. Ukrayinskyi pulmonolohichnyi zhurnal – Ukr. Pulmonol. J., 1, 5-14 [in Ukrainian].

Jin, X., Lian, J.S., Hu, J.H., Gao, J., Zheng, L., Zhang, Y.M., & Yang, Y. (2020). Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms. Gut, 69(6), 1002-1009. DOI: 10.1136/gutjnl-2020-320926.

Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., & Pöhlmann, S. (2020). SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell, 181(2), 271-280.e8. DOI: 10.1016/j.cell.2020.02.052.

Zou, X., Chen, K., Zou, J., Han, P., Hao, J., & Han, Z. (2020). Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection. Front. Med., 14(2), 185-192. DOI: 10.1007/s11684-020-0754-0.

Sultan, S., Altayar, O., Siddique, S.M., Davitkov, P., Feuerstein, J.D., Lim, J.K., …, & El-Serag, H.B. (2020). AGA institute rapid review of the gastrointestinal and liver manifestations of COVID-19, meta-analysis of international data, and recommendations for the consultative management of patients with COVID-19. Gastroenterology, 159(1), 320-334.e27. DOI: 10.1053/j.gastro.2020.05.001.

(2020). Tizhnevyi zvit pro ryzyky dlia hromadskoho zdorovia [Weekly report on public health risks]. Retrieved from: https://phc.org.ua/sites/default/files/users/user90/risk_2020_42.pdf [in Ukrainian].

Tukalo, М.А. (2021). Pro uchast vchenykh NAN Ukrainy v protydii COVID-19. Rozroblennia diahnostychnykh system, likarskykh zasobiv i monitorynh nebezpechnykh shtamiv: Za materialamy dopovidi na zasidanni Prezydii NAN Ukrainy 9 chervnia 2021 roku [On the participation of scientists of the NAS of Ukraine in counteracting COVID-19. Development of diagnostic systems, drugs and monitoring of dangerous strains: According to the materials of report at the meeting of the Presidium of NAS of Ukraine, June 9, 2021]. Visnyk Natsionalnoi Academii nauk Ukrayiny – Bulletin of the National Academy of Sciences of Ukraine, 8, 56-61 [in Ukrainian].

“Symptomy 7-8 dniv, a potim saturatsiia kysniu rizko padaie”. Ochilnik MOZ rozpoviv pro osoblivosti shtamu “Delta” v Ukraini ["Symptoms of 8 days, and then oxygen saturation drops sharply." The head of the Ministry of Health spoke about the peculiarities of the Delta strain in Ukraine]. Retrieved from: https://moz.gov.ua/article/interview/simptomi-7-8-dniv-a-potim-saturacija-kisnju-rizko-padae-ochilnik-moz-rozpoviv-pro-osoblivosti-shtamu-delta-v-ukraini [in Ukrainian].

(2020). Pro zatverdzhennia protokolu «Nadannia medychnoi dopomohy dlia likuvannia koronavirusnoi khvoroby (COVID-19)» [On approval of the protocol "Amendments to the Standards of Medical Care “Coronavirus Disease (COVID19)"]. Nakaz Ministerstva okhorony zdorovia Ukrainy vid 2.04.2020 r. № 762 (v redaktsii nakazu Ministerstva okhorony zdorovia Ukrainy vid 31 hrudnia 2020 roku № 3094) – Order of the Ministry of Health of Ukraine of 2 April 2020 No. 762 – (as amended by the order of the Ministry of Health of Ukraine from 31 December 2020 No. 3094)]. Retrieved from: https://moz.gov.ua/uploads/5/28069-dn_ 3094_31_12_2020_dod.pdf [in Ukrainian].

(2021). Pro zatverdzhennia protokolu «Nadannia medychnoi dopomohy dlia likuvannia koronavirusnoi khvoroby (COVID-19)» [On approval of the protocol "Amendments to the Standards of Medical Care “Coronavirus Disease (COVID19)"]. Nakaz Ministerstva okhorony zdorovia Ukrainy vid 2.04.2020 r. No. 762 (v redaktsii nakazu Ministerstva okhorony zdorovia Ukrainy vid 06 kvitnia 2021 roku № 638) – Order of the Ministry of Health of Ukraine of 2 April 2020 No. 762 (as amended by the order of the Ministry of Health of Ukraine from 06 April 2021 No. 638)]. Retrieved from: https://moz.gov.ua/uploads/5/29766-dn_638_06_04_2021_dod.pdf [in Ukrainian].

(2021). Pro zatverdzhennia protokolu «Nadannia medychnoi dopomohy dlia likuvannia koronavirusnoi khvoroby (COVID-19)» [On approval of the protocol "Amendments to the Standards of Medical Care “Coronavirus Disease (COVID19)"]. Nakaz Ministerstva okhorony zdorovia Ukrainy vid 2.04.2020 № 762. (v redaktsii nakazu Ministerstva okhorony zdorovia Ukrainy vid 20 veresnia 2021 r. № 1979) – Order of the Ministry of Health of Ukraine of April 2020 No. 762 (as amended by the order of the Ministry of Health of Ukraine from 06 September 2021 No. 1979)]. Retrieved from: https://moz.gov.ua/uploads/5/29766-dn_638_06_04_2021_dod.pdf [in Ukrainian].

Fetisov, V.S. (2018). Paket statystychnoho analizu danykh STATISTICA: navch. posib [STATISTICA statistical data analysis package: textbook]. Nizhyn: NDU im. M. Hoholia [in Ukrainian].

Published

2022-03-25

How to Cite

Pertseva, T. O., Konopkina, L. I., Belosludtseva, K. O., Myronenko, O. V., Botvinikova, L. A., Shchudro, O. O., & Huba, Y. V. (2022). PECULIARITIES OF LEVEL OF THE GASTROINTESTINAL TRACT IN CORONAVIRUS DISEASE (COVID-19) IN DIFFERENT WAVES OF THE PANDEMIC. Achievements of Clinical and Experimental Medicine, (4), 151–155. https://doi.org/10.11603/1811-2471.2021.v.i4.12514

Issue

Section

Оригінальні дослідження